MarcusSNoelMD

Oncology • Washington, DC

Hematologic Oncology

Medical director of the Clinical Trials Office

Join to view full profile

Dr. Noel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Noel's full profile

Already have an account?

Office
3800 Reservoir Rd NW
Washington, DC 20007
Phone+1 202-444-2223

Education & Training

University of RochesterFellowship, Hematology and Medical Oncology, 2011 - 2014
University of RochesterResidency, Internal Medicine, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008

Certifications & Licensure

VA State Medical License 2021 - 2026
DC State Medical License 2019 - 2024
MD State Medical License 2022 - 2023
NY State Medical License 2010 - 2020
American Board of Internal Medicine Medical Oncology

Clinical Trials

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Start of enrollment: 2017 Oct 06
Completed
Phase 2
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator

Publications & Presentations

PubMed

10 citations
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways.
Chao Yin, Ali Alqahtani, Marcus S Noel
Cancers. 2022-05-25
1 citations
Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).
Benjamin A Weinberg, Hongkun Wang, Marcus S Noel, Aiwu R He, John L Marshall
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01
84 citations
Disparities in Pancreatic Cancer Treatment and Outcomes.
Marcus Smith Noel, Kevin Fiscella
Health Equity. 2019-10-29

Press Mentions

Let’s Talk About: Pancreatic Cancer’s Impact on Black AmericansFebruary 4th, 2022
ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GIJanuary 24th, 2022
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic CancerAugust 24th, 2021
Join now to see all